Fingerprint
Dive into the research topics of 'Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study
Avivit Cahn, Itamar Raz, Marc Bonaca, Ofri Mosenzon, Sabina A. Murphy, Ilan Yanuv, Aliza Rozenberg, John P.H. Wilding, Deepak L. Bhatt, Darren K. McGuire, Ingrid A.M. Gause-Nilsson, Martin Fredriksson, Peter A. Johansson, Gyorgy Jermendy, Samy Hadjadj, Anna Maria Langkilde, Marc S. Sabatine, Stephen D. Wiviott, Lawrence A. Leiter
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations